ITMI991894A0 - Acido linoleico coniugato e trigliceride nuovi metodi di sintesi e d'u so - Google Patents

Acido linoleico coniugato e trigliceride nuovi metodi di sintesi e d'u so

Info

Publication number
ITMI991894A0
ITMI991894A0 IT99MI001894A ITMI991894A ITMI991894A0 IT MI991894 A0 ITMI991894 A0 IT MI991894A0 IT 99MI001894 A IT99MI001894 A IT 99MI001894A IT MI991894 A ITMI991894 A IT MI991894A IT MI991894 A0 ITMI991894 A0 IT MI991894A0
Authority
IT
Italy
Prior art keywords
triglyceride
synthesis
linoleic acid
new methods
conjugated linoleic
Prior art date
Application number
IT99MI001894A
Other languages
English (en)
Inventor
Carlo Ghisalberti
Original Assignee
Carlo Ghisalberti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Carlo Ghisalberti filed Critical Carlo Ghisalberti
Priority to IT1999MI001894A priority Critical patent/ITMI991894A1/it
Publication of ITMI991894A0 publication Critical patent/ITMI991894A0/it
Priority to BR0013897-5A priority patent/BR0013897A/pt
Priority to KR1020027003093A priority patent/KR100703142B1/ko
Priority to PCT/IB2000/001277 priority patent/WO2001017374A1/en
Priority to PCT/IB2000/001274 priority patent/WO2001018161A2/en
Priority to JP2001521290A priority patent/JP2003508479A/ja
Priority to CA002384028A priority patent/CA2384028A1/en
Priority to ES00954854T priority patent/ES2261228T3/es
Priority to PCT/IB2000/001280 priority patent/WO2001017498A1/en
Priority to CNB008140022A priority patent/CN1157181C/zh
Priority to AU67203/00A priority patent/AU6720300A/en
Priority to EP00954854A priority patent/EP1214048B1/en
Priority to US10/088,004 priority patent/US6953583B1/en
Priority to DE60027016T priority patent/DE60027016T2/de
Priority to AT00954854T priority patent/ATE321525T1/de
Priority to AU67200/00A priority patent/AU6720000A/en
Priority to AU67205/00A priority patent/AU6720500A/en
Publication of ITMI991894A1 publication Critical patent/ITMI991894A1/it
Priority to JP2010258620A priority patent/JP2011063609A/ja

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A61K31/231—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having one or two double bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/31—Hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/35—Ketones, e.g. benzophenone
    • A61K8/355—Quinones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/361—Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/368—Carboxylic acids; Salts or anhydrides thereof with carboxyl groups directly bound to carbon atoms of aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A61K8/375—Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4953—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom containing pyrimidine ring derivatives, e.g. minoxidil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4986—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with sulfur as the only hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/55—Phosphorus compounds
    • A61K8/553—Phospholipids, e.g. lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/602—Glycosides, e.g. rutin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63—Steroids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/676—Ascorbic acid, i.e. vitamin C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/678—Tocopherol, i.e. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/06—Preparations for care of the skin for countering cellulitis
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11C—FATTY ACIDS FROM FATS, OILS OR WAXES; CANDLES; FATS, OILS OR FATTY ACIDS BY CHEMICAL MODIFICATION OF FATS, OILS, OR FATTY ACIDS OBTAINED THEREFROM
    • C11C3/00—Fats, oils, or fatty acids by chemical modification of fats, oils, or fatty acids obtained therefrom
    • C11C3/04—Fats, oils, or fatty acids by chemical modification of fats, oils, or fatty acids obtained therefrom by esterification of fats or fatty oils
    • C11C3/06—Fats, oils, or fatty acids by chemical modification of fats, oils, or fatty acids obtained therefrom by esterification of fats or fatty oils with glycerol
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11C—FATTY ACIDS FROM FATS, OILS OR WAXES; CANDLES; FATS, OILS OR FATTY ACIDS BY CHEMICAL MODIFICATION OF FATS, OILS, OR FATTY ACIDS OBTAINED THEREFROM
    • C11C3/00—Fats, oils, or fatty acids by chemical modification of fats, oils, or fatty acids obtained therefrom
    • C11C3/14—Fats, oils, or fatty acids by chemical modification of fats, oils, or fatty acids obtained therefrom by isomerisation
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
IT1999MI001894A 1999-09-09 1999-09-09 Acido linoleico coniugato e trigliceride nuovi metodi di sintesi e d'uso ITMI991894A1 (it)

Priority Applications (18)

Application Number Priority Date Filing Date Title
IT1999MI001894A ITMI991894A1 (it) 1999-09-09 1999-09-09 Acido linoleico coniugato e trigliceride nuovi metodi di sintesi e d'uso
AU67205/00A AU6720500A (en) 1999-09-09 2000-09-08 Use of conjugated linoleic acid (cla) for the topical treatment of cellulite
PCT/IB2000/001280 WO2001017498A1 (en) 1999-09-09 2000-09-08 Use of conjugated linoleic acid (cla) for the topical treatment of cellulite
AU67203/00A AU6720300A (en) 1999-09-09 2000-09-08 Compositions comprising conjugated linoleic acid (cla)
PCT/IB2000/001277 WO2001017374A1 (en) 1999-09-09 2000-09-08 Compositions comprising conjugated linoleic acid (cla)
PCT/IB2000/001274 WO2001018161A2 (en) 1999-09-09 2000-09-08 Process for the preparation of conjugated linoleic acid (cla)
JP2001521290A JP2003508479A (ja) 1999-09-09 2000-09-08 セルライトの局所治療のための共役化リノール酸（ｃｌａ）の使用
CA002384028A CA2384028A1 (en) 1999-09-09 2000-09-08 Use of conjugated linoleic acid (cla) for the topical treatment of cellulite
ES00954854T ES2261228T3 (es) 1999-09-09 2000-09-08 Utilizacion de acido linoleico conjugado (cla) para el tratamiento topico de la celulitis.
BR0013897-5A BR0013897A (pt) 1999-09-09 2000-09-08 Uso de ácido linoleico conjugado (cla) ou de um seu derivado, composição tópica cosmética ou dermatológica, e, método de tratamento e/ou de profilaxia de celulite e de depósitos de gordura
CNB008140022A CN1157181C (zh) 1999-09-09 2000-09-08 共轭亚油酸(cla)用于蜂窝组织炎的局部护理的用途
KR1020027003093A KR100703142B1 (ko) 1999-09-09 2000-09-08 셀룰라이트의 국소 치료를 위한 공액 리놀레산(ｃｌａ)의용도
EP00954854A EP1214048B1 (en) 1999-09-09 2000-09-08 Use of conjugated linoleic acid (cla) for the topical treatment of cellulite
US10/088,004 US6953583B1 (en) 1999-09-09 2000-09-08 Use of conjugated linoleic acid (CLA) for the topical treatment of cellulite
DE60027016T DE60027016T2 (de) 1999-09-09 2000-09-08 Verwendung von konjugierten linolensaüren zur topischen behandlung von zellulitis
AT00954854T ATE321525T1 (de) 1999-09-09 2000-09-08 Verwendung von konjugierten linolensaüren zur topischen behandlung von zellulitis
AU67200/00A AU6720000A (en) 1999-09-09 2000-09-08 New process for the preparation of conjugated linoleic acid (cla)
JP2010258620A JP2011063609A (ja) 1999-09-09 2010-11-19 セルライトの局所治療のための共役化リノール酸（ｃｌａ）の使用

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT1999MI001894A ITMI991894A1 (it) 1999-09-09 1999-09-09 Acido linoleico coniugato e trigliceride nuovi metodi di sintesi e d'uso

Publications (2)

Publication Number Publication Date
ITMI991894A0 true ITMI991894A0 (it) 1999-09-09
ITMI991894A1 ITMI991894A1 (it) 2001-03-09

Family

ID=11383591

Family Applications (1)

Application Number Title Priority Date Filing Date
IT1999MI001894A ITMI991894A1 (it) 1999-09-09 1999-09-09 Acido linoleico coniugato e trigliceride nuovi metodi di sintesi e d'uso

Country Status (13)

Country Link
US (1) US6953583B1 (it)
EP (1) EP1214048B1 (it)
JP (2) JP2003508479A (it)
KR (1) KR100703142B1 (it)
CN (1) CN1157181C (it)
AT (1) ATE321525T1 (it)
AU (3) AU6720500A (it)
BR (1) BR0013897A (it)
CA (1) CA2384028A1 (it)
DE (1) DE60027016T2 (it)
ES (1) ES2261228T3 (it)
IT (1) ITMI991894A1 (it)
WO (3) WO2001017374A1 (it)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001060331A2 (en) * 2000-02-15 2001-08-23 Zen-Bio, Inc. Compositions for preventing cellulite in mammalian skin
AU2005242170B2 (en) * 2000-06-26 2008-12-18 The Procter & Gamble Company Compositions and methods for body weight management
US7025984B1 (en) * 2000-06-26 2006-04-11 The Procter & Gamble Company Compositions and methods for body weight management
WO2002079139A1 (de) * 2001-03-29 2002-10-10 Basf Aktiengesellschaft Konjugierte ungesättigte glyceridgemische und verfahren zur ihrer herstellung
EP1302114A3 (en) * 2001-10-16 2004-01-14 Loders Croklaan B.V. Mixtures for stimulating glucose up-take
US6677470B2 (en) * 2001-11-20 2004-01-13 Natural Asa Functional acylglycerides
ITMI20021280A1 (it) * 2002-06-11 2003-12-11 Carlo Ghisalberti Metodo di trattamento anticellulite
US20040228884A1 (en) * 2003-05-15 2004-11-18 Gupta Shyam K. Ion-pair delivery system for cosmetic and pharmaceutical compositions
DE10317109A1 (de) * 2003-04-14 2004-11-11 Cognis Deutschland Gmbh & Co. Kg Zubereitungen zur oralen Aufnahme
CN101829028A (zh) * 2003-06-17 2010-09-15 Dsmip资产公司 含有植烷酸或其衍生物的局部用制剂
EP1541037A1 (de) * 2003-12-04 2005-06-15 Cognis Deutschland GmbH & Co. KG Zubereitung zur oralen Aufnahme enthaltend Extrakte von Passiflora incarnata
FR2865402B1 (fr) * 2004-01-27 2006-04-28 Inst Phytoceutic Composition amaigrissante par voie orale comprenant de l'acide linoleique conjugue et de la cafeine.
CA2559974C (en) * 2004-03-17 2012-08-14 Nestec S.A. Compositions and methods for reducing or preventing obesity
EP1586244A1 (de) * 2004-04-16 2005-10-19 Cognis IP Management GmbH Zubereitungen für die orale Aufnahme
ATE480301T1 (de) 2004-06-15 2010-09-15 Boots Co Plc Haarpflegezusammensetzungen und verfahren
EP1618885A1 (en) * 2004-07-10 2006-01-25 Cognis IP Management GmbH Cosmetic and/or pharmaceutical compositions containing fatty acids and extracts of castanea sativa
EP1656934A1 (en) * 2004-11-12 2006-05-17 Cognis IP Management GmbH Use of physiologically active fatty acids for treating lipodystrophy
FR2883472B1 (fr) * 2005-03-23 2010-09-03 Rocher Yves Biolog Vegetale Utilisation d'un acide chlorogenique en tant qu'un actif amincissant
EP2368442B1 (en) 2005-07-27 2014-12-17 Symrise AG Use of hesperetin for enhancing the sweet taste
EP1956923A1 (en) 2005-11-02 2008-08-20 Nestec S.A. Isoflavone compositions for reducing accumulation of body fat in male mammals, and methods for their use
US7172754B1 (en) 2005-12-23 2007-02-06 Conopco, Inc. Cosmetic emulsions with sunscreens and conjugated linoleic acid
US7175836B1 (en) 2005-12-23 2007-02-13 Conopco, Inc. Oil continuous phase cosmetic emulsions with conjugated linoleic acid
US7175835B1 (en) 2005-12-23 2007-02-13 Conopco, Inc. Cosmetic emulsions with inorganic sunscreens stabilized with conjugated linoleic acid
WO2007116579A1 (ja) * 2006-04-07 2007-10-18 Kao Corporation 脂肪分解促進剤
US20080025917A1 (en) * 2006-04-10 2008-01-31 Malcolm Whitman Methods for modulating formation and progression of cellulite
DE102007009650A1 (de) * 2007-02-26 2008-08-28 Beiersdorf Ag Kosmetisches Kombinationsprodukt zur Verbesserung des äußeren Erscheinungsbildes
JP5165299B2 (ja) * 2007-07-20 2013-03-21 ポーラ化成工業株式会社 皮膚外用剤
TWI395593B (zh) 2008-03-06 2013-05-11 Halozyme Inc 可活化的基質降解酵素之活體內暫時性控制
EP2307001A1 (en) * 2008-06-11 2011-04-13 BioChemics, Inc. Control of blood vessel physiology to treat skin disorders
WO2010019210A2 (en) 2008-08-11 2010-02-18 President And Fellows Of Harvard College Halofuginone analogs for inhibition of trna synthetases and uses thereof
MX349176B (es) 2008-09-22 2017-07-14 Biochemics Inc Suministro transdermico de farmaco empleando un osmolito y un agente vasoactivo.
PT104241B (pt) 2008-10-29 2012-03-06 Stargate Produtos Farmaceuticos Dieteticos E Nutricionais Lda Composições incorporando agentes redutores da celulite e inestetismos associados e formulações que as contêm
US9278233B2 (en) 2008-12-04 2016-03-08 Biochemics, Inc. Methods and compositions for tattoo removal
KR101119877B1 (ko) * 2009-03-03 2012-02-28 (주)에이치케이바이오텍 지방감소를 위한 피부도포용 조성물 및 이것의 제조방법
EP2414047B1 (en) * 2009-04-03 2013-01-16 Oriflame Cosmetics SA Topical cosmetic compositions for treating or preventing cellulite
AU2010313249B2 (en) 2009-10-30 2016-05-19 Biojiva Llc Alleviating oxidative stress disorders with PUFA derivatives
KR102020579B1 (ko) 2011-04-26 2019-09-10 레트로토프 인코포레이티드 에너지 프로세싱 손상 장애 및 미토콘드리아 결함
AU2012249921B2 (en) 2011-04-26 2017-06-08 Biojiva Llc Oxidative retinal diseases
AU2012249917B2 (en) 2011-04-26 2017-06-15 Biojiva Llc Neurodegenerative disorders and muscle diseases implicating PUFAs
CA2834343C (en) * 2011-04-26 2021-10-12 Retrotope, Inc. Disorders implicating pufa oxidation
US8809560B2 (en) 2011-05-17 2014-08-19 Board Of Trustees Of The University Of Arkansas Trans-, trans-conjugated linoleic acid compositions and use thereof
NZ750379A (en) 2012-01-12 2022-10-28 Auxilium Int Holdings Inc Clostridium histolyticum enzymes and methods for the use thereof
US10155742B2 (en) 2012-01-13 2018-12-18 President And Fellows Of Harvard College Halofuginol derivatives and their use in cosmetic and pharmaceutical compositions
CN104125848A (zh) * 2012-02-29 2014-10-29 雅芳产品公司 Cpt-1调节剂的用途及其组合物
CN104603616B (zh) * 2012-09-07 2017-03-08 株式会社资生堂 使用纤蛋白‑3和/或肌聚糖γ作为指标评价脂肪团的方法和评价脂肪团有效药物的方法
US9062276B2 (en) 2012-12-03 2015-06-23 Board Of Trustees Of The University Of Arkansas Conjugated linoleic acid rich vegetable oil production from linoleic rich oils by heterogeneous catalysis
US9463155B2 (en) 2013-03-15 2016-10-11 Mary Kay Inc. Cosmetic compositions and uses thereof
CN103385516A (zh) * 2013-07-29 2013-11-13 安徽燕之坊食品有限公司 一种液体补充物
CA2938992A1 (en) * 2014-02-11 2015-08-20 Elc Management Llc Method, compositions, and kit for modulating the appearance of volume on keratin surfaces
US9833393B2 (en) * 2015-09-24 2017-12-05 Elc Management Llc Method and compositions for treating skin
US10730821B2 (en) 2015-11-23 2020-08-04 Retrotope, Inc. Site-specific isotopic labeling of 1,4-diene systems
BR112019018277A2 (pt) 2017-03-01 2020-06-30 Endo Ventures Limited aparelho e método para avaliar e tratar celulite
MX2019011574A (es) 2017-03-28 2019-12-19 Endo Ventures Ltd Método mejorado para producir aplicaciones relacionadas con la colagenasa.
WO2019237125A1 (en) 2018-06-08 2019-12-12 The General Hospital Corporation Inhibitors of prolyl-trna-synthetase
WO2021168311A1 (en) 2020-02-21 2021-08-26 Retrotope, Inc. Processes for isotopic modification of polyunsaturated fatty acids and derivatives thereof

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL130652C (it) * 1959-08-24
CH399431A (fr) * 1962-07-13 1965-09-30 Biorex Laboratories Ltd Procédé de préparation de l'acide 18-alpha-glycyrrhétinique
DE2049937A1 (en) * 1970-10-10 1972-04-13 Rhodium or ruthenium complexes and metal halides - as isomerisation catalysts for conjugated diene prodn
US4164505A (en) * 1977-07-08 1979-08-14 Sylvachem Corporation Flow process for conjugating unconjugated unsaturation of fatty acids
FR2474310A1 (fr) * 1980-01-25 1981-07-31 Oreal Solution stable a l'oxydation de vitamine f et d'huile de jojoba et compositions cosmetiques la contenant
US5208356A (en) * 1989-02-17 1993-05-04 Wisconsin Alumni Research Foundation Octadecadienoic phospholipic esters, antioxidant and mold inhibiting compositions
AU5448490A (en) * 1989-04-24 1990-11-16 Board Of Regents, The University Of Texas System Compositions and processes for improving the cosmetic appearance, growths or healing characteristics of tissue
FR2669537B1 (fr) * 1990-11-28 1993-02-19 Oreal Composition amincissante a base d'alpha-2-bloqueurs.
FR2678622B1 (fr) * 1991-07-03 1994-11-18 Adir Nouveaux complexes de vanadium, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
US5554646A (en) * 1992-04-29 1996-09-10 Wisconsin Alumni Research Foundation Method for reducing body fat in animals
US5814663A (en) * 1994-08-29 1998-09-29 Wisconsin Alumni Research Foundation Method for maintaining an existing level of body fat
JP3452986B2 (ja) * 1994-09-13 2003-10-06 花王株式会社 脂肪分解促進剤
JPH08245403A (ja) * 1995-03-07 1996-09-24 Baker Norton Pharmaceut Inc インシュリン抵抗性症候群治療用組成物
DE69609196T3 (de) * 1995-11-14 2006-01-26 Loders Croklaan B.V. Verfahren zur Herstellung von Materialien mit hohem Gehalt an isomeren von konjugierter Linolsäure
JP4104180B2 (ja) * 1996-05-08 2008-06-18 一丸ファルコス株式会社 リパーゼ活性促進剤
US5667793A (en) * 1996-08-02 1997-09-16 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Skin care compositions for treating cellulite
JPH10101546A (ja) * 1996-09-27 1998-04-21 Shiseido Co Ltd 皮膚外用剤
GB9621630D0 (en) 1996-10-17 1996-12-11 Kappa Pharmaceuticals Ltd Treatment of skin disorders
JP3017108B2 (ja) * 1996-10-30 2000-03-06 リノール油脂株式会社 共役リノール酸の製造方法
DE19718245C5 (de) * 1997-04-30 2004-11-11 Cognis Deutschland Gmbh & Co. Kg Synthetische Triglyceride auf Basis konjugierter Linolsäure, Verfahren zu deren Herstellung und deren Verwendung
JP4129566B2 (ja) 1997-09-05 2008-08-06 大塚製薬株式会社 肝臓脂肪蓄積抑制組成物及び肝臓脂肪蓄積抑制用食品添加剤
US6019990A (en) * 1997-11-21 2000-02-01 Natural Nutrition Ltd. As Conjugated linoleic acid delivery system in cosmetic preparations
US6136985A (en) * 1997-12-23 2000-10-24 Dcv, Inc. CLA esters and uses thereof
US6262019B1 (en) * 1998-04-30 2001-07-17 Vit-Immune, L. C. Method of treatment of glutathione deficient mammals
WO2000001351A1 (en) * 1998-07-07 2000-01-13 Transdermal Technologies, Inc. Compositions for rapid and non-irritating transdermal delivery of pharmaceutically active agents and methods for formulating such compositions and delivery thereof
US6413545B1 (en) * 1998-09-01 2002-07-02 Access Business Group International Llc Diet composition and method of weight management
GB9828379D0 (en) * 1998-12-22 1999-02-17 Unilever Plc Skin care composition
AU4402600A (en) * 1999-05-18 2000-12-05 Rawlings, Anthony V. Fat containing products
WO2001060331A2 (en) * 2000-02-15 2001-08-23 Zen-Bio, Inc. Compositions for preventing cellulite in mammalian skin

Also Published As

Publication number Publication date
JP2003508479A (ja) 2003-03-04
US6953583B1 (en) 2005-10-11
KR100703142B1 (ko) 2007-04-05
AU6720000A (en) 2001-04-10
AU6720300A (en) 2001-04-10
JP2011063609A (ja) 2011-03-31
BR0013897A (pt) 2002-05-14
ES2261228T3 (es) 2006-11-16
EP1214048A1 (en) 2002-06-19
WO2001017498A1 (en) 2001-03-15
CN1378441A (zh) 2002-11-06
WO2001017374A1 (en) 2001-03-15
WO2001018161A3 (en) 2001-11-01
AU6720500A (en) 2001-04-10
CA2384028A1 (en) 2001-03-15
DE60027016D1 (de) 2006-05-18
WO2001018161A2 (en) 2001-03-15
KR20030005156A (ko) 2003-01-17
EP1214048B1 (en) 2006-03-29
ATE321525T1 (de) 2006-04-15
CN1157181C (zh) 2004-07-14
DE60027016T2 (de) 2006-11-30
ITMI991894A1 (it) 2001-03-09

Similar Documents

Publication Publication Date Title
ITMI991894A0 (it) Acido linoleico coniugato e trigliceride nuovi metodi di sintesi e d'u so
MA26930A1 (fr) Esters oxygenes d'acides 4-iodophenylamino- benzhydroxamiques
ITPD940043A0 (it) "esteri attivi di polisaccaridi carbossilici"
PT0900782E (pt) Ester do acido 2-cianacrilico
FR11C0035I2 (fr) Suspensions aqueuses d'esters d'acides gras de 9-hydroxyrisperidone
CY2010006I1 (el) Πολυμορφικες τροποποιησεις του 2-(3-κυανο-4-ισοβουτυλοξυφαινυλ)-4-μεθυλ-5-θειαζολοκαρβοξυλικου οξεος και μεθοδοι παρασκευης αυτων
SG82079A1 (en) Method of producing carboxylic acid and alcohol
NO20026001D0 (no) 3'-promedikamenter av 2'-deoksy-<Beta>-L-nukleosider
EE200200286A (et) Uued aminopropüülfosfiinhapped ning nende kasutamine
PL364171A1 (en) Crystals of an oxyiminoalkanoic acid derivative and their use as antidiabetics
DE59501040D1 (de) Quaternierte Triethanolaminfettsäureester
IT1298271B1 (it) Esteri ed ammidi dell'acido 2-oxo-2,3-diidro-benzimidazol-1- carbossilico
FR2782638B1 (fr) Utilisation en cosmetique d'acides gras
ITMI921559A0 (it) Esteri amminoalchilcarbanici dell'eserolina atti all'impiego come anticolinesterasici e relativo procedimento di preparazione
FR2802852B3 (fr) Production d'elements figures
NO20022361D0 (no) Fremgangsmåte for fremstilling av konjugert linolsyre
FR2760635B1 (fr) Procede de preparation d'une composition cosmetique a base de platre et composition cosmetique ainsi obtenue
PL335062A1 (en) Derivatives of phenoxyacetic acid and their application as herbicides
FR2799122B1 (fr) Production d'un complexe lipidique vegetal comme agent cosmetique et nutraceutique
IT1293734B1 (it) Procedimento per la fabbricazione di ruote di turbine idrauliche e ruote cosi' ottenute
NO20012266D0 (no) Fremgangsmåte for fremstilling av L-DOPA-etylester
DE69817868D1 (de) 4-fluoro-3-oxocarbonsäureester und ihre herstellung
IT1291622B1 (it) Uso dell'acido tioglicolico come agente depigmentante
AU1354201A (en) Compositions and methods of synthesis and use of novel nucleic acid structures
NO20014449L (no) Fremgangsmåte for fremstilling av 5-amino-8- alkylkinolonkarboksylsyrederivater og mellomprodukter ifremstillingen derav